Investing.com -- 领先的血栓切除公司Penumbra, Inc. (NYSE:PEN)报告的第二季度盈利超过了分析师预期,公布后股价上涨7%。 这家医疗设备制造商在2025年第二季度实现收入3.395亿美元,超过了分析师预期的3.2777亿美元,比去年同期增长13.4%。调整后每股收益为0.86美元,超过分析师预期的0.83美元。 Penumbra的美国血栓切除业务表现尤为突出,...
Source LinkInvesting.com -- 领先的血栓切除公司Penumbra, Inc. (NYSE:PEN)报告的第二季度盈利超过了分析师预期,公布后股价上涨7%。 这家医疗设备制造商在2025年第二季度实现收入3.395亿美元,超过了分析师预期的3.2777亿美元,比去年同期增长13.4%。调整后每股收益为0.86美元,超过分析师预期的0.83美元。 Penumbra的美国血栓切除业务表现尤为突出,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.